The teaching hospital of Southern University of Science and Technology — one of China's fastest-rising research universities. Built with purpose-designed research infrastructure, SUSTech Hospital offers precision oncology, active biotech clinical trials, and genomic diagnostics, with typically shorter waiting times than Shenzhen's older public hospitals. It may be a suitable option for the right case — particularly patients seeking trial access or faster diagnostics — but whether it's the appropriate choice for your situation depends on your diagnosis and objectives. China Care helps you work that out before you travel, then provides bilingual escort and coordination throughout your stay.
SUSTech Hospital (南方科技大学医院) is the affiliated teaching hospital of Southern University of Science and Technology (SUSTech), one of China's most prominent new research universities. SUSTech was founded in 2011 and rapidly achieved global university rankings through its focus on STEM research and international academic collaboration — its hospital inherits the same ethos of rigorous science and rapid innovation.
SUSTech Hospital traces its roots to the former Xili People's Hospital and was reorganised as the Southern University of Science and Technology affiliated hospital in 2018. Today it operates as a tertiary (Grade 3) comprehensive public teaching hospital with a research-driven mandate — combining an established clinical base with modern diagnostic equipment, purpose-designed clinical research facilities, and workflows supporting both standard care and active biotech trials. The hospital has established dedicated precision oncology, genomic medicine, and robotic orthopaedics units that leverage the university's research capabilities. A new surgical tower (Phase II) is currently under construction to expand capacity.
Patients choosing SUSTech Hospital over Shenzhen's older public hospitals consistently cite two advantages: shorter waiting times for outpatient appointments and diagnostics, and access to cancer treatment clinical trials and precision medicine protocols not yet available at established hospitals. For international patients seeking cutting-edge diagnostics or trial access, SUSTech offers a compelling combination of research depth and operational efficiency.
As a relatively newer hospital in its current SUSTech-affiliated form (reorganised in 2018), SUSTech has not yet accumulated the same decades of outpatient demand as Shenzhen's longest-established institutions. International patients typically report shorter waiting times for consultations and faster turnaround on diagnostic results — particularly for NGS genomic panels and advanced imaging. For patients who need answers quickly, this operational efficiency is a significant advantage.
SUSTech's university affiliation creates direct access to biotech-sponsored clinical trials not available at stand-alone hospitals. For patients with solid tumours or haematological malignancies who have exhausted standard treatment options, trial eligibility at SUSTech Hospital may open therapeutic avenues unavailable elsewhere in Shenzhen. China Care coordinates trial eligibility review prior to your arrival.
In its current research-hospital form, SUSTech Hospital houses diagnostic equipment and clinical research infrastructure that older hospitals struggle to retrofit. Genomic sequencing, precision imaging, and molecular pathology facilities are purpose-designed and continuously upgraded. For international patients who have been treated at leading hospitals in the US, UK, or Singapore, the standard of equipment is immediately recognisable.
Finding a hospital's name is easy. Knowing whether it's actually the right one for your situation is much harder — that's where China Care helps.
Most international patients researching SUSTech Hospital are unsure whether it's genuinely the right fit for their case, or whether another hospital might serve them better. China Care helps you answer questions like:
A research-driven hospital with active programmes spanning precision oncology, genomic diagnostics, biotech clinical trials, and robotic-assisted orthopaedics. The departments most commonly accessed through China Care are listed below.
Finding a hospital is the easy part. Understanding whether it's the right one for your situation is harder — China Care guides you through that, from initial guidance through to on-the-ground support in Shenzhen.
Send your complete records: pathology reports, existing genomic sequencing results (if available), imaging, and treatment history. This step is free and helps us understand whether SUSTech Hospital — or another hospital — may be worth exploring for your case. If you are interested in trial access, we flag your case to the clinical trials team simultaneously.
free · 1–2 daysIf it makes sense to go further, Case Investigation looks into whether this hospital is genuinely a suitable option for your case — before you commit to travelling. Depending on your situation, this may include medical record review, department identification, specialist discussion, and a proxy consultation with the relevant specialist where appropriate, with the outcome reported back to you with voice call interpretation in real time. This is a paid service, covering hospital registration and coordination, agreed with you upfront. Already in China? Skip this step — China Care can arrange direct escort and interpretation for your own visit instead.
case investigation · fixed fee · trial eligibility assessedIf Case Investigation confirms this is a suitable option, you travel to Shenzhen for your own in-person consultation. The specialist reviews your case in person, confirms the treatment plan, and provides a formal cost estimate — this step cannot be completed remotely at a public hospital. China Care's bilingual coordinator accompanies you throughout. For precision oncology cases, NGS genomic profiling is typically initiated at or shortly after this appointment.
in-person consultation · treatment plan & cost estimate issuedChina Care's coordinator accompanies you through key clinical appointments — particularly for treatment planning discussions, informed consent, and procedural preparation. For patients accessing biotech trial protocols, China Care coordinates all trial documentation, eligibility paperwork, and communications with the research team throughout the process. All treatment fees are paid directly to the hospital in Chinese yuan (RMB). No international credit cards for inpatient treatment. A deposit is required at admission.
China Care on site · RMB payment direct to hospitalUpon discharge, patients receive a full bilingual discharge summary including genomic results, treatment summary, and follow-up recommendations. Remote follow-up consultations are available via video for ongoing precision medicine monitoring. China Care coordinates communication between SUSTech Hospital and your home oncology team throughout the post-treatment period.
bilingual documentation · remote follow-upWhichever stage you're at, China Care's role is the same: help you make an informed decision, not just a booking.
Understand your options before travelling — including whether SUSTech Hospital or another hospital is a suitable fit for your case.
Learn more →Appointments, interpreters, and hospital coordination once you're ready to move forward.
Learn more →Support before, during, and after treatment in China — from admission through to follow-up care.
Learn more →We'll help you understand whether SUSTech Hospital — or another hospital in China — may be a better option for your situation.
China Care coordinates your case with SUSTech Hospital. We handle pre-admission documentation, translation, and trial eligibility review. Treatment costs quoted directly by the hospital — zero treatment markup from China Care.